Extinguishing burnout for pediatric oncology physicians
Prevention, intervention and even plug-in applications can help when long hours and administrative burdens raise the risk of physician burnout.
Read More
Category: Clinical Care
Obesity: the side effect of therapy we don’t consider
Treatment for pediatric cancers can cause obesity – which presents a new set of immediate and long-term issues. A study found early intervention is critical to prevent obesity during and after treatment.
Read More
Cancer drugs for children in critically short supply
Chemotherapy agents are consistently among the drug classes in short supply, and it threatens the treatment of children with cancer.
Read More
A global alliance to take the care of St. Jude to the world
The St. Jude Global Alliance is a collaboration of institutions dedicated to increasing access to care and improving the quality of health care delivery for children with cancer and other catastrophic diseases.
Read More
Learn the basics of CAR T-cell therapy and how it is being used in the SJCAR19 clinical trial at St. Jude
CAR T-cell therapy has generated excitement throughout the medical community as a treatment for many types of cancer. But what is this treatment and how does it work? Learn the basics of CAR T-cell therapy and how it is being used in the SJCAR19 clinical trial at St. Jude.
Read MoreGut microbiome sequencing opens new possibilities for predicting infection in leukemia patients
Infectious diseases researchers Hana Hakim, Jason Rosch and their team sequenced gut microbiome bacteria to help predict the risk of infections during chemotherapy for children with acute lymphoblastic leukemia.
Read More
New drug for a rare disorder: How will Gamifant’s approval affect HLH treatment?
Drug approved to treat hemophagocytic lymphohistiocytosis, better known as HLH. A rare disorder of the immune system, the condition can lead to severe organ damage and death.
Read More
St. Jude community partnership highlighted during World AIDS Day
New HIV/AIDS diagnoses are on the rise for younger people. St. Jude has formed a community partnership with area groups to reach out to young people with education, prevention and treatment measures.
Read More
Targeted therapy larotrectinib could make tumors with rare NTRK fusion genes less lethal
Learn how this newly approved cancer drug scored high patient response rates by inhibiting a rare chromosomal abnormality that drives tumor growth.
Read MoreSurgery team gives young patient a Halloween surprise
A patient was bummed out because she was going to miss Halloween, but her doctors and nurses had a plan.
Read More
Precision medicine has a role in the cures of the future
As a scientist who studies genomics and how it relates to leukemia, I read with interest the...
Read More
Pediatric otolaryngology: Taking care of ears, noses and throats
Many people are surprised to learn that hundreds of children travel to St. Jude Children’s...
Read More
Recent Posts
Recent Videos